Tilray Brands, Inc. ($TLRY) Earnings (Q3 FY22)

 Tilray Brands, Inc. ($TLRY) Earnings and Opinion:


Tilray Brands is a company in the Healthcare sector and operates in the Drug Manufacturers-Specialty and Generic industry. The company creates and distributes medical cannabis products. Tilray was incorporated in 2018 and is currently headquartered in New York, New York. The company made its debut on the stock market in the middle part of 2018.

Tilray Brands, Inc. EPS and Revenue (Q3 FY22):

  • EPS of $0.09 beating expectations of -$0.08
  • Revenue of $152M missing expectations of $158.72M
  • EPS was up 108.7% (YOY) and Revenue was up 23% (YOY)
Tilray Brands, Inc. Q3 Highlights:
  • Net Income of $52.5M
  • Adjusted EBITA of $10.1M
  • Gross Profit increased 31% (YOY) to $39.8M
Tilray Brands, Inc. News and Outlook:
  • Achieve target of $4B in revenue by end of FY24
  • Has a near 20% share in Germany now
  • Maintained #1 leading market share position under intense competition
Opinion:
Tilray Brands, Inc. is currently moving higher in pre-market after reporting earnings this morning. Cannabis stocks have seen extremely volatility due to all the rules and regulations in different places. However, Tilray is trying to eliminate all of that and prove it is a legitimate business that can put up big numbers. Apparent by its $4B revenue target that it is set to achieve by the end of fiscal year 2024. Tilray reported a profitable quarter with EPS coming in at $0.09 a share, but it missed revenue expectations. I think investors will look over this and get to the main part, which was they were able to turn a profit and grow revenue by 23% (YOY) still. Gross profit increased by 31% coming in at $39.8M, but surprisingly non-operating income played a huge role in a profitable quarter for this company. Personally, I have not really been interested in cannabis stocks. However, I think Tilray is one I would definitely consider if I had to pick one. I would keep an eye out for a bill lingering in Congress right now that would legalize cannabis in the US. This could lead to huge moves for cannabis companies as they will have a bigger market to work with. For now though, cannabis stocks are extremely risky due to regulation, but some of them could turn out to be some big winners over time. 


*Information from Yahoo Finance, Tilray Brands, and Nasdaq
*Estimates attained from Zacks

Comments

Post a Comment

Popular posts from this blog

Weekly Earnings Review: September 25, 2023- September 29, 2023

     It was a nice little break in the earnings report, but just like that we are back! We are slowly easing our way back into earnings season. However, this week marked the end of Q3 and September. September was a downturn from the rally we saw earlier in the year. There is a lot of stuff looming as the government is set to shut down on October 1st. The Fed is keeping a close eye on inflation but this weeks prints showed some signs of improvement. The average consumer is struggling as savings keep dwindling. In terms of our earnings, we just had two companies that reported this week. One is a warehouse style retailer and the other is a wide range consulting firm.  Tuesday, September 26, 2023 Costco Wholesale Corporation (COST)-     Costco beat expectations on both the top and bottom line. The stock saw a decline after the initial earnings report, but by the end of the week it has hit a new 52-week high. The revenue growth was impressive as it grew by a hair under 10%. The COGS growth
Read more

Weekly Earnings Review: October 16, 2023- October 20, 2023

      Well earnings season is finally among us, so we will start producing more beefier blog posts and cover a lot more companies over these next few weeks. I had one company report last week that I decided to throw into this weeks post, because I felt that it was pointless to make a post with just one boring company. With the inclusion of that company, we will cover 7 companies that report earnings this week and will give your our thoughts and opinions on how they performed during the quarter and the outlook. There is a lot of controversy going on with a war breaking out in Israel and the House of Representatives with out a speaker. This year seems to be the year of how geopolitics affect the market. There seems to be a lot of confusion with the outlook of the market right now, but inflation numbers still look to be fair and the earnings of major companies will be able to tell us a little bit more about where this is headed.  Thursday, October 12, 2023 Walgreens Boots Alliance (WBA)-
Read more

Weekly Earnings Review: November 27, 2023- December 1, 2023

Image
     Stocks continue to rise as we enter the final month of trading for the year. The S&P 500 and Nasdaq had another stellar month. Bond yields continue to fall, as interest rates have seemed to reach their peak. Estimates are all over the place when it comes to when cutting will start and how many cuts we will see next year. I added a new mantra to particular companies. I want to add some visual pieces to the post to entice the readers. Hope you guys enjoy the visuals and the excerpts. Stay investing! Monday, November 27, 2023 Zscaler (ZS)-      Zscaler continues to carry its momentum, as the company beat on both the top and bottom lines. The company achieved 40% growth on the top line and saw impressive growth on the bottom line as well. Management raised guidance and are expecting around 30% growth on both the top and bottom line. What is so impressive about this company is that they are achieving high growth and high profitability. This is a feat that a lot of software companie
Read more